TherapeuticsMD (TXMD) Gains from Investment Securities (2011 - 2025)
TherapeuticsMD (TXMD) reported Gains from Investment Securities of $105000.0 for Q4 2025, little changed on a YoY basis from $105000.0 in Q4 2024, and up 105.88% quarter-over-quarter from $51000.0 in Q3 2025.
TherapeuticsMD (TXMD) Gains from Investment Securities (2011 - 2025) Analysis & Trends
TherapeuticsMD has reported Gains from Investment Securities for 15 years, with the latest figure at $105000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities changed 0.0% year-over-year to $105000.0; the trailing twelve-month figure through Dec 2025 stood at $105000.0 (changed 0.0% YoY), and the FY2025 full-year result was $105000.0, changed 0.0% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at $105000.0, up from $51000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $23.5 million in Q2 2021, with the low at -$721000.0 in Q3 2023.
- Historically, Gains from Investment Securities has averaged $1.6 million across 5 years, with a median of $52000.0 in 2025.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities slumped 48400.0% — and 2025, when it soared 75262.32%.
- TherapeuticsMD's Gains from Investment Securities stood at -$39000.0 in 2021, then soared by 541.03% to $172000.0 in 2022, then soared by 1243.6% to $2.3 million in 2023, then plunged by 95.46% to $105000.0 in 2024, then changed by 0.0% to $105000.0 in 2025.
- The last three Gains from Investment Securities figures came in at $105000.0 (Q4 2025), $51000.0 (Q3 2025), and $51000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | TherapeuticsMD | 21,180.42 | -8.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 105,000.00 |
| Dec 31, 2025 | 105,000.00 |
| Sep 30, 2025 | 51,000.00 |
| Sep 30, 2025 | 51,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | 105,000.00 |
| Dec 31, 2024 | 105,000.00 |
| Sep 30, 2024 | 62,000.00 |
| Sep 30, 2024 | 62,000.00 |
| Jun 30, 2024 | 63,000.00 |
| Jun 30, 2024 | 63,000.00 |
| Mar 31, 2024 | 69.00 |
| Mar 31, 2024 | 69.00 |
| Dec 31, 2023 | 2.31 Mn |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | -721,000.00 |
| Sep 30, 2023 | -721,000.00 |